BrainTalk

Company Overview

Snapshot

Founded in March 2016 by Vadim Kagan, Sari Maril, VS Subrahmanian, and Ayala Bloch, BrainTalk operated with 1–10 employees. The company ceased operations in October 2020.

Business overview

BrainTalk developed a software solution designed to quickly and accurately detect cognitive deficits using a five-minute speech sample. The company's patent-pending intelligent algorithm was capable of identifying cognitive impairments resulting from stroke, aging, disease, and medical interventions like chemotherapy. BrainTalk aimed to provide health and sports organizations with a non-invasive, cost-effective, and repeatable tool for screening and monitoring large populations with known or suspected brain damage. The company operated within the Digital Health and Medical Technologies sector, leveraging artificial intelligence, machine learning, and speech analytics.

Company Intelligence Q&A

What is BrainTalk's primary offering?

BrainTalk developed software that detects cognitive deficits based on a five-minute speech sample, utilizing a patent-pending intelligent algorithm.

When was BrainTalk founded?

BrainTalk was founded in March 2016.

Who are the co-founders of BrainTalk?

The co-founders of BrainTalk are Vadim Kagan, Sari Maril, VS Subrahmanian, and Ayala Bloch.

What markets did BrainTalk target?

BrainTalk's technology was designed for health and sports organizations to screen and monitor populations with known or suspected brain damage.

What is the current status of BrainTalk?

BrainTalk ceased to operate in October 2020.